Phytomedicine,
Год журнала:
2025,
Номер
143, С. 156889 - 156889
Опубликована: Май 21, 2025
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
growing
global
health
concern
linked
to
increased
risks
of
cardiovascular
disease,
chronic
kidney
(CKD),
and
premature
mortality.
Ginkgo
biloba
has
shown
potential
therapeutic
benefits
in
conditions
characterized
by
metabolic
dysfunction.
This
study
aimed
evaluate
the
protective
effects
supplementation
on
overall
survival
(OS)
incidence
renal
outcomes
specifically
MASLD
patients.
cohort
included
402,476
participants
from
UK
Biobank,
categorized
into
No
(SLD)
cohorts.
users
non-users
were
compared
using
inverse
probability
treatment
weighting
balance
baseline
characteristics.
Clinical
assessed
Cox
proportional
hazards
models,
with
subgroup
analyses.
was
associated
significantly
improved
OS
[hazard
ratio
(HR)
=
0.79,
95
%
confidence
interval
(CI):
0.64-0.98,
p
0.034)
reduced
events
(HR
0.82,
CI:
0.66-1.00,
0.012)
CKD
0.73,
0.56-0.96,
cohort,
while
no
significant
observed
SLD
cohort.
Subgroup
analyses
indicated
enhanced
older
adults,
males,
individuals
BMI
≥
25
kg/m²,
diabetic
The
beneficial
pronounced
patients
advanced
fibrosis.
patients,
particularly
high-risk
subgroups.
These
findings
highlight
as
an
adjunctive
therapy
management.
first
large-scale
examine
impact
clinical
MASLD,
fibrosis-stratified
providing
insights
its
differential
across
severity.
Cardiovascular Diabetology,
Год журнала:
2025,
Номер
24(1)
Опубликована: Фев. 7, 2025
Cardiovascular
diseases
represent
the
principal
cause
of
death
and
comorbidity
among
people
with
diabetes.
Ferroptosis,
an
iron-dependent
non-apoptotic
regulated
cellular
characterized
by
lipid
peroxidation,
is
involved
in
pathogenesis
diabetic
cardiovascular
diseases.
The
susceptibility
to
ferroptosis
hearts
possibly
related
myocardial
iron
accumulation,
abnormal
metabolism
excess
oxidative
stress
under
hyperglycemia
conditions.
Accumulating
evidence
suggests
can
be
therapeutic
target
for
This
review
summarizes
ferroptosis-related
mechanisms
novel
choices
targeting
pathways.
Further
study
on
ferroptosis-mediated
cardiac
injury
enhance
our
understanding
pathophysiology
provide
more
potential
choices.
Non-alcoholic
fatty
liver
disease
(NAFLD),
recently
redefined
as
metabolic
dysfunction-associated
steatotic
(MASLD),
is
the
most
common
cause
of
chronic
worldwide.
Characterized
by
excessive
hepatic
fat
accumulation,
this
encompasses
a
spectrum
from
simple
steatosis
to
more
severe
forms,
including
steatohepatitis,
fibrosis,
and
cirrhosis.
Emerging
evidence
highlights
pivotal
role
gut
dysbiosis
in
pathogenesis
MASLD.
Dysbiosis
disrupts
gut–liver
axis,
an
intricate
communication
network
that
regulates
metabolic,
immune,
barrier
functions.
Alterations
microbiota
composition,
increased
permeability,
translocation
pro-inflammatory
metabolites/factors
have
been
shown
trigger
inflammatory
fibrotic
cascades,
exacerbating
inflammation
injury.
Recent
studies
identified
microbiome
signatures
associated
with
MASLD,
offering
promise
non-invasive
diagnostic
biomarkers
paving
way
for
new
potential
therapeutic
strategies
targeting
dysbiosis.
This
review
explores
crucial
MASLD
need
further
targeted
research
field
validate
microbial
optimize
strategies.
Comprehensive
understanding
axis
may
enable
innovative
approaches,
transforming
clinical
management
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(7), С. 2441 - 2441
Опубликована: Апрель 3, 2025
Background/Objectives:
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
prevalent
condition
worldwide,
with
significant
regional
variability
in
prevalence
estimates.
This
study
aimed
to
determine
the
prevalence,
demographic
characteristics,
and
economic
burden
of
MASLD,
metabolic
(MASL),
steatohepatitis
(MASH)
Valencian
Community
region
Spain.
Methods:
We
conducted
retrospective
analysis
electronic
medical
records
from
public
healthcare
database
individuals
aged
over
24
years
2012
2019.
Results:
Of
3,411,069
included
2019,
75,565
were
diagnosed
74,065
MASL,
1504
MASH
based
on
International
Classification
Diseases
(ICD),
corresponding
2.22%,
2.17%,
0.04%,
respectively.
Among
type
2
diabetes
mellitus
(T2DM)
or
obesity,
MASLD
was
approximately
three
times
2.5
higher,
respectively,
compared
overall
population.
The
increased
2019
all
populations
studied.
highest
risk
hospitalization
associated
liver-related
causes,
followed
by
all-cause
hospitalization.
cost
per
subject
observed
concomitant
T2DM.
Conclusions:
Our
findings
indicate
rising
MASH,
despite
their
potential
underdiagnosis
during
period.
presence
high
costs,
particularly
patients
results
underline
need
for
more
effective
strategies
enhance
awareness
improve
resource
allocation.
Circulation Research,
Год журнала:
2025,
Номер
136(11), С. 1170 - 1207
Опубликована: Май 22, 2025
Over
the
past
few
decades,
rising
burden
of
metabolic
disease,
including
type
2
diabetes,
prediabetes,
obesity,
and
dysfunction–associated
steatotic
liver
has
corresponded
with
fundamental
shifts
in
landscape
heart
failure
(HF)
epidemiology,
prevalence
HF
preserved
ejection
fraction.
It
become
increasingly
important
to
understand
role
extracardiac
contributors
interorgan
communication
pathophysiology
phenotypic
heterogeneity
HF.
Whereas
traditional
epidemiological
strategies
have
separately
examined
individual
contributions
specific
comorbidities
risk,
these
approaches
may
not
capture
shared
mechanisms
more
complex,
bidirectional
relationships
between
cardiac
noncardiac
comorbidities.
In
this
review,
we
highlight
cardiac,
kidney,
liver,
metabolism
multiorgan
interactions
pathways
that
complicate
development
progression
propose
research
further
context
multiple
organ
disease.
This
includes
evolving
such
as
multiomics
machine
learning
which
better
common
underlying
crosstalk.
We
review
existing
preclinical
models
how
they
enhanced
our
understanding
disease
subtypes.
suggest
recommendations
clinical
practice
across
specialties
should
screen
for
manage
involvement
Finally,
recognizing
advent
novel
combinatorial
therapeutic
agents
indications
cardiac-kidney-liver
continuum,
current
trials
landscape.
specifically
a
pressing
need
design
inclusive
examine
multimorbidity
incorporate
end
points,
lead
outcomes
are
evermore
clinically
relevant
today.
Medicina,
Год журнала:
2025,
Номер
61(2), С. 247 - 247
Опубликована: Фев. 1, 2025
Background
and
Objectives:
The
pathogenesis
of
metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
remains
incompletely
understood.
However,
recent
studies
highlight
the
interactions
between
muscle,
liver,
adipose
tissue.
This
study
aimed
to
explore
relationships
clinical
indicators
MASLD
sarcopenia,
cardiorespiratory
fitness,
fatigue,
mood.
Materials
Methods:
involved
60
participants,
including
28
healthy
controls
32
with
MASLD,
categorized
into
two
subgroups:
15
MASL
17
steatohepatitis
(MASH).
Participants
completed
an
incremental
speed
shuttle
walk
test
evaluate
a
hand-held
dynamometer
assessment
for
appendicular
muscle
strength,
timed
up
go
physical
performance.
Physical
activity
level,
quality
life,
emotional
state
were
assessed
using
questionnaires.
results
compared
groups
characteristics.
Results:
MASH
showed
reduced
fitness
(p
<
0.001).
knee
extensors
significantly
weaker
in
both
0.001
p
=
0.001,
respectively).
group
reported
higher
levels
depression
negative
health
perception
0.006
0.03,
Muscle
strength
patients
significant
association
(OR
−0.384,
95%
CI:
−3.10
−0.74,
0.003),
intrahepatic
triglyceride
content
−0.287,
−1.31
−0.11,
0.023),
LDL
−0.286,
−0.02
−0.33,
0.03).
In
contrast,
positive
was
observed
VO2
0.531,
CI
1.27
3.47,
Conclusions:
suggests
that
is
linked
key
parameters,
such
as
hepatic
fat,
levels,
aerobic
capacity,
may
contribute
development
progression
MASLD.
Interventions
at
preserving
or
enhancing
be
essential
preventing
damage
improving
health.
Nutrients,
Год журнала:
2025,
Номер
17(3), С. 600 - 600
Опубликована: Фев. 6, 2025
Background
and
aims:
The
Mediterranean
diet
(MedDiet)
is
a
healthy
dietary
pattern
associated
with
reduced
risk
of
chronic
diseases.
However,
adherence
declining,
particularly
among
younger
populations.
Therefore,
it
crucial
to
identify
the
main
aspects
that
affect
its
adherence,
food
preferences
sensory
function,
which
have
received
insufficient
attention.
Our
aims
were
investigate
impact
socio-demographic
lifestyle
factors
on
MedDiet
young
individuals;
assess
association
taste
liking
adherence;
evaluate
associations
between
perception
modalities,
preferences,
adherence.
Methods:
A
cross-sectional
study
adults
(aged
20.5
±
4.7
years)
in
country
(n
=
879)
was
carried
out.
Demographic
characteristics,
clinical
anthropometric
assessed.
Taste
for
bitter,
salty,
sweet,
sour,
umami
determined
by
rating
different
concentrations
prototypical
tastants.
We
computed
total
score
three
scores
combine
preferences.
Results:
identified
several
MedDiet,
as
well
determinants.
Food
significantly
MedDiet.
Higher
preference
olive
oil,
oranges,
broccoli,
fish,
legumes
higher
(p
<
0.05
all).
Conversely,
sweet
foods,
red
meat,
butter
lower
combined
positive
strongly
1.4
×
10−23)
multivariate
adjusted
model.
negative
inversely
1.9
10−8).
Likewise,
(strong
inverse
direct
bitter
preference;
both
p
0.001).
Moreover,
foods
0.05).
In
conclusion,
future
precision
nutrition
studies
should
measure
are
determinants
especially
people.